Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Venturelli

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The International Journal of Biological Markers|December 20, 2011
Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional studyGiorgio Secreto, Elisabetta Meneghini, Elisabetta Venturelli, et al.
Epidemiologia E Prevenzione|September 14, 2020
Adherence to the 2018 WCRF/AICR recommendations and sleep behaviour in people with metabolic syndromeEleonora Bruno, Eliana Roveda, Giuliana Gargano, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohortEva S Schernhammer, Franco Berrino, Vittorio Krogh, et al.
Journal of the National Cancer Institute|June 12, 2008
Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal womenEva S Schernhammer, Franco Berrino, Vittorio Krogh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2007
Plasma testosterone and prognosis of postmenopausal breast cancer patientsAndrea Micheli, Elisabetta Meneghini, Giorgio Secreto, et al.
Nutrients|May 10, 2019
Monitoring Vitamin B<sub>12</sub> in Women Treated with Metformin for Primary Prevention of Breast Cancer and Age-Related Chronic DiseasesAntonio Mastroianni, Chiara Maura Ciniselli, Rossella Panella, et al.
Plos One|March 25, 2022
Recruitment in randomized clinical trials: The MeMeMe experienceIvan Baldassari, Andreina Oliverio, Vittorio Krogh, et al.
Neurology. Clinical Practice|January 7, 2022
Erenumab Discontinuation After 12-Month Treatment: A Multicentric, Observational Real-Life StudyFrancesca Schiano di Cola, Salvatore Caratozzolo, Elisabetta Venturelli, et al.
Journal of Cellular Physiology|April 6, 2011
Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapyValentina Ciravolo, Veronica Huber, Gaia C Ghedini, et al.
Plos One|February 23, 2019
A management system for randomized clinical trials: A novel way to supply medicationMauro Cortellini, Alice Casagrande, Giuseppe Fornaciari, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The International Journal of Biological Markers|December 20, 2011
Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional studyGiorgio Secreto, Elisabetta Meneghini, Elisabetta Venturelli, et al.
Epidemiologia E Prevenzione|September 14, 2020
Adherence to the 2018 WCRF/AICR recommendations and sleep behaviour in people with metabolic syndromeEleonora Bruno, Eliana Roveda, Giuliana Gargano, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohortEva S Schernhammer, Franco Berrino, Vittorio Krogh, et al.
Journal of the National Cancer Institute|June 12, 2008
Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal womenEva S Schernhammer, Franco Berrino, Vittorio Krogh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2007
Plasma testosterone and prognosis of postmenopausal breast cancer patientsAndrea Micheli, Elisabetta Meneghini, Giorgio Secreto, et al.
Nutrients|May 10, 2019
Monitoring Vitamin B<sub>12</sub> in Women Treated with Metformin for Primary Prevention of Breast Cancer and Age-Related Chronic DiseasesAntonio Mastroianni, Chiara Maura Ciniselli, Rossella Panella, et al.
Plos One|March 25, 2022
Recruitment in randomized clinical trials: The MeMeMe experienceIvan Baldassari, Andreina Oliverio, Vittorio Krogh, et al.
Neurology. Clinical Practice|January 7, 2022
Erenumab Discontinuation After 12-Month Treatment: A Multicentric, Observational Real-Life StudyFrancesca Schiano di Cola, Salvatore Caratozzolo, Elisabetta Venturelli, et al.
Journal of Cellular Physiology|April 6, 2011
Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapyValentina Ciravolo, Veronica Huber, Gaia C Ghedini, et al.
Plos One|February 23, 2019
A management system for randomized clinical trials: A novel way to supply medicationMauro Cortellini, Alice Casagrande, Giuseppe Fornaciari, et al.
Pageof 6